Xiidra (lifitegrast ophthalmic solution) — Medica

Initial criteria

• Patient has a diagnosis of dry eye disease (including dry eye syndrome or keratoconjunctivitis sicca)
• age ≥ 18 years

Reauthorization criteria

• Patient continues to have a diagnosis of dry eye disease (including dry eye syndrome or keratoconjunctivitis sicca)
• age ≥ 18 years

Approval duration

1 year